Santavirta, S. et al. Aggressive granulomatous lesions related to hip arthroplasty: Inmunopathological research. J. Bone Joint Surg. [Am.] 72A, 252–258. https://doi.org/10.3109/17453678909150108 (1990).
Schmalzried, T. P. et al. The mechanism of loosening of cemented acetabular parts in whole hip arthroplasty: Evaluation of specimens retrieved at post-mortem. Clin. Orthop. Relat. Res. 274, 60–78 (1992).
Amstutz, H. C., Campbell, P., Kossovsky, N. & Clarke, I. C. Mechanism and scientific significance of wear and tear particles induced osteolysis. Clin. Orthop. Relat. Res. 276, 7–18 (1992).
Jiranek, W. A. et al. Manufacturing of cytokines round loosened cemented acetabular parts: Evaluation with inmunohistochemical strategies and in situ hibridization. J. Bone Joint Surg. [Am.] 75A, 863–879. https://doi.org/10.2106/00004623-199306000-00007 (1993).
Wooley, P. H. & Schwarz, E. M. Aseptic loosening. Gene Ther. 11, 402–407. https://doi.org/10.1038/sj.gt.3302202 (2004).
Norredin, S. & Masri, B. Periprosthetic osteolysis: Genetics, mechanisms and potential therapeutic interventions. J. Can. Chir. 55, 408–417. https://doi.org/10.1503/cjs.003711 (2012).
Wallach, S., Avioli, L. V., Feinblatt, J. D. & Carstens, J. H. Jr. Cytokines and bone metabolism. Calcif. Tissue Int. 53, 293–296. https://doi.org/10.1007/BF01351830 (1993).
Kurori, T., Shingu, M., Koshihara, Y. & Nobunaga, M. Results of cytokines on alkaline phosphatase and osteocalcin manufacturing, calcification and calcium launch by human osteoblastic cells. Br. J. Rheumatol. 33, 224–230. https://doi.org/10.1093/rheumatology/33.3.224 (1994).
Chiba, J., Rubash, H. E., Kim, Okay. J. & Iwaki, Y. The characterization of cytokines within the interface tissue obtained from failed cementless whole hip arthroplasty with and with out femoral osteolysis. Clin. Orthop. Relat. Res. 300, 304–312 (1994).
Pociot, F., Molvig, J., Wogensen, L., Worsaae, H. & Nerup, J. A. TaqI polymorphism within the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur. J. Clin. Make investments. 22, 396–402. https://doi.org/10.1111/j.1365-2362.1992.tb01480.x (1992).
McDowell, T. L., Symons, J. A., Ploski, R., Forre, O. & Duff, G. W. Genetic affiliation between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum. 38, 221–228. https://doi.org/10.1002/artwork.1780380210 (1995).
D’Alfonso, S., Colombo, G., Della-Bella, S., Scorza, R. & Momigliano-Richiardi, P. P. Affiliation between polymorphism within the TNF area and systemic lupus erythematosus within the Italian inhabitants. Tissue Antigens 47, 551–555. https://doi.org/10.1111/j.1399-0039.1996.tb02598.x (1996).
Stuber, F., Petersen, M., Bokelmann, F. & Schade, U. A genomic polymorphism throughout the tumor necrosis issue locus influences plasma tumor necrosis factor-alpha concentrations and end result of sufferers with extreme sepsis. Crit. Care Med. 24, 381–384. https://doi.org/10.1097/00003246-199603000-00004 (1996).
Wilkinson, J. M. et al. Variation within the TNF gene promoter and danger of osteolysis after whole hip arthroplasty. J. Bone Miner. Res. 18, 1995–2001. https://doi.org/10.1359/jbmr.2003.18.11.1995 (2003).
Kolundzic, R., Orlic, D., Trkulja, V., Pavelic, Okay. & Troselj, Okay. G. Single nucleotide polymorphisms within the interleukin-6 gene promoter, tumor necrosis factor-alpha gene promoter, and reworking progress factor-beta1 gene sign sequence as predictors of time to onset of aseptic loosening after whole hip arthroplasty: Preliminary research. J. Orthop. Sci. 11, 592–600. https://doi.org/10.1007/s00776-006-1069-y (2006).
Gallo, J., Mrazek, F. & Petrek, M. Variation in cytokine genes can contribute to severity of acetabular osteolysis and danger for revision in sufferers with ABDG I whole hip arthroplasty: A genetic affiliation research. BMC Med. Genet. 10, 109. https://doi.org/10.1186/1471-2350/10/109 (2009).
Del Buono, A., Denaro, V. & Maffulli, N. Genetic susceptibility to aseptic loosening following whole hip arthroplasty: A scientific overview. Br. Med. Bull. 101, 39–55. https://doi.org/10.1093/bmb/ldr011 (2012).
Asensi, V. et al. IL-1α (-889) promoter polymorphism is a danger issue for osteomyelitis. Am. J. Med. Gen. 119A, 132–136. https://doi.org/10.1128/IAI.72.7.3823-3828.2004 (2003).
Knight, J. Polymorphisms in tumor necrosis issue and different cytokines as dangers for infectious ailments and the septic syndrome. Curr. Infect. Dis. Rep. 3, 427–439. https://doi.org/10.1007/s11908-007-1010-3 (2001).
Smith, A. J. et al. Prolonged haplotypes and linkage disequilibrium within the IL1R1-IL1A-IL1B-IL1RN gene cluster: Affiliation with knee osteoarthritis. Genes Immunity 5, 451–460. https://doi.org/10.1038/sj.gene.6364107 (2004).
Sampaio Fernandes, M., Vaz, P., Braga, A. C., Sampaio Fernandes, J. C. & Figueiral, M. H. The position of IL-1 gene polymorphisms (IL-1A, IL1B, and IL1RN) as a danger consider unsuccesful implant retaining overdentures. J. Prosthodont. Res. 61, 439–449. https://doi.org/10.1016/j.jpor.2017.01.004 (2017).
Ralston, S. H. et al. Nitric oxide: A cytokine-induced regulator of bone resorption. J. Bone Miner. Res. 10, 1040–1049. https://doi.org/10.1002/jbmr.5650100708 (1995).
Van’tHof, R. J. & Ralston, S. Nitric oxide and bone. Immunology 2001(103), 255–261. https://doi.org/10.1046/j.1365-2567.2001.01261.x (2001).
Michell, B. J. et al. The Akt kinase indicators on to endothelial nitric oxide synthase. Curr. Biol. 9, 845–848. https://doi.org/10.1016/s0960-9822(99)80371-6 (1999).
Armour, Okay. E. et al. Faulty bone formation and anabolic response to exogenous estrogen in mice with focused disruption of endothelial nitric oxide synthase. Endocrinology 142, 760–766. https://doi.org/10.1210/endo.142.2.7977 (2001).
Aguirre, J. et al. Endothelial nitric oxide synthase gene-deficient mice show marked retardation in postnatal bone formation, diminished bone quantity, and defects in osteoblast maduration and exercise. Am. J. Pathol. 158, 247–257. https://doi.org/10.1016/S0002-9440(10)63963-6 (2001).
Asensi, V. et al. The NOS3 (27-bp repeat, intron 4) polymorphism is related to susceptibility to osteomyelitis. Nitric Oxide 16, 44–53 (2007).
Taylor, B. C. et al. Affiliation of endothelial nitric oxide synthase genotypes with bone mineral density, bone loss, hip construction, and danger of fracture in older ladies. The SOF research. Bone 39, 174–180. https://doi.org/10.1016/j.niox.2006.06.00 (2006).
Pascual, M. et al. Genetic determinants of rheumathoid arthritis: the inducible nitric oxide synthase (NOS2) gene promoter polymorphism. Genes Immun. 3, 299–301. https://doi.org/10.1038/sj.gene.6363856 (2002).
Gonzalez-Homosexual, M. A. et al. Inducible however not endothelial nitric oxide synthase polymorphism is related to susceptibility to rheumatoid arthritis in Northwest Spain. Rheumatology 43, 1182–1185. https://doi.org/10.1093/rheumatology/keh283 (2004).
Cataldo, M. A., Petrosillo, N., Cipriani, M., Cauda, R. & Tacconelli, E. Prosthetic joint an infection.current developments in analysis and administration. J. Infect. 61, 443–448. https://doi.org/10.1016/j.inf.2010.09.033 (2010).
Stahelova, A., Mrazek, F., Smizansky, M., Petrek, M. & Gallo, J. Variation within the IL1B, TNF and IL6 genes and particular person susceptibility to prosthetic joint an infection. BMC Immunol. 13, 25. https://www.biomedcentral.com/1471-21-2172/13/25 (2012).
Zhou, X. et al. Genetic susceptibility to prosthetic joint an infection following whole joint arthroplasty: A scientific overview. Gene 563, 76–82. https://doi.org/10.1016/j.gene.2015.03.005 (2015).
Osmon, D. R. et al. Analysis and administration of prosthetic joint an infection: Medical follow pointers by the Infectious Illnesses Society of America. Clin. Infect. Dis. 56, e1-125. https://doi.org/10.1093/cid/cis803 (2013).
Miller, S. A., Dykes, D. D. & Polesky, H. F. A easy salting out process for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215–1222. https://doi.org/10.1093/nar/16.3.1215 (1988).
Giovannoni, G., Land, J. M., Keir, G., Thompson, E. J. & Heales, S. J. Adaptation of the nitrate reductase and Griess response strategies for the measurement of serum nitrate plus nitrite ranges. Ann. Clin. Biochem. 34, 193–198. https://doi.org/10.1177/000456329703400212 (1997).
Malchau, H., Herberts, P. & Ahnfelt, L. Prognosis of whole hip alternative in Sweden: Comply with-up of 92.675 operations carried out 1978–1990. Acta Ortop. Scand. 64, 497–506. https://doi.org/10.3109/17453679308993679 (1993).
Eskelinen, A. et al. Complete hip arthroplasty for major osteoarthrosis in youthful sufferers within the Finnish arthroplasty register: 4,661 major replacements adopted for 0–22 years. Acta Orthop. 76, 28–41. https://doi.org/10.1080/00016470510030292 (2005).
Ranawat, C. S., Flynn, W. F., Saddler, S., Hansraj, Okay. Okay. & Maynard, M. J. Lengthy-term outcomes of the overall condylar knee arthroplasty. A 15-year survivorship research. Clin. Orthop. Relat. Res. 286, 94–102 (1993).
Maloney, W. J. Aseptic failure in whole knee arthroplasty. In Revision Complete Knee Arthroplasty (eds Engh, G. A. & Rorabek, C. H.) 46–60 (Williams & Wilkins, 1997).
Mangaleshkar, S. R., Bajaj, S. Okay. & Thomas, A. P. Denham whole knee arthroplasty: A ten-year follow-up research. J Arthroplasty 17, 550–555. https://doi.org/10.1054/arth.2002.31976 (2002).
Crowe, J. F., Sculco, T. P. & Kahn, B. Revision whole hip arthroplasty: Hospital price and reimbursement evaluation. Clin. Orthop. Relat. Res. 413, 175–182. https://doi.org/10.1097/01.blo.0000072469.32680.b6 (2003).
Paprosky, W. G., Weeden, S. H. & Bowling, J. W. Jr. Element removing in revision whole hip artrhoplasty. Clin. Orthop. Relat. Res. 393, 181–193. https://doi.org/10.1097/00003086-200112000-00021 (2001).
Granchi, D. et al. Bone-resorbing cytokines in serum of sufferers with aseptic loosening of hip prosthesis. J. Bone Joint Surg. Br. 80B, 912–917. https://doi.org/10.1302/0301-620x.80b5.8513 (1998).
Haynes, D. R., Rogers, S. D., Hay, S., Pearcy, M. J. & Howie, D. W. The variations in toxicity and launch of bone-resorbing mediators induced by titanium and cobalt-chromium-alloy put on particles. J. Bone Joint Surg. Am. 75A, 825–834. https://doi.org/10.2106/00004623-199306000-00004 (1993).
Glant, T. T. et al. Particulate-induced prostaglandin- and cytokine mediated bone resorption in an experimental system and in failed joint replacements. Am. J. Therapeut. 3, 27–41. https://doi.org/10.1097/00045391-199601000-00006 (1996).
Goodman, S. B. et al. A clinical-pathologic-biochemical research of the membrane surrounding loosened and non-loosened whole hip arthroplasties. Clin. Orthop. Relat. Res. 244, 182–187 (1989).
Kobayashi, Okay. et al. Tumor necrosis issue alpha stimulates osteoclast differentiation by a mechanism impartial of the OD/RANKL-RANK interplay. J. Exp. Med. 191, 275–286. https://doi.org/10.1084/jem.191.2.275 (2000).
Langhdahl, B. L., Lokke, E., Carstens, M., Stenkjaer, L. L. & Eriksen, E. F. Osteoporotic fractures are related to an 86-base pair repeat polymorphism within the interleukin-1 receptor antagonist gene, however not with polymorphisms within the interleukin-1β gene. J. Bone Miner. Res. 15, 402–414. https://doi.org/10.1359/jbmr.2000.15.3.402 (2000).
Nicklin, M. J., Weith, A. & Duff, G. W. A bodily map of the area encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics 19, 382–384. https://doi.org/10.1006/geno.1994.1076 (1994).
Lopez, N. J., Jara, L. & Valenzuela, C. Y. Affiliation of interleukin-1 polymorphisms with periodontal illness. J. Periodontol. 76, 234–243. https://doi.org/10.1902/jop.2005.76.2.234 (2005).
Feloutzis, A. et al. IL-1 gene polymorphism and smoking as danger components for peri-implant bone loss in a well-maintained inhabitants. Clin. Oral Implants Res. 14, 10–17. https://doi.org/10.1034/j.1600-0501.2003.140102.x (2003).
Gruica, B., Wang, H. Y., Lang, N. P. & Buser, D. Influence of IL-1 genotype and smoking standing on the prognosis of osseointegrated implants. Clin. Oral Implants Res. 15, 393–400. https://doi.org/10.1111/j.1600-0501.2004.01026.x (2004).
Jansson, H., Hamberg, Okay., De Bruyn, H. & Bratthall, G. Medical penalties of IL-1 genotype on early implant failures in sufferers underneath periodontal upkeep. Clin. Implant Dent. Relat. Res. 7, 51–59. https://doi.org/10.1111/j.1708-8208.2005.tb00047.x (2005).
Kornman, Okay. S. & Duff, G. W. Candidate genes as potential hyperlinks between periodontal and cardiovascular ailments. Ann. Periodontol. 6, 48–57. https://doi.org/10.1902/annals.2001.6.1.48 (2001).
Buchs, N. et al. IL-1B and IL-1Ra gene polymorphisms and illness severity in rheumatoid arthritis: Interplay with their plasma ranges. Genes Immun. 2, 222–228. https://doi.org/10.1038/sj.gene.6363766 (2001).
McDevitt, M. J., Russell, C. M., Schmid, M. J. & Reinhardt, R. A. Influence of elevated occlusal contact, interleukin-1 genotype, and periodontitis severity on gingival crevicular fluid IL-1 beta ranges. J. Periodontol. 74, 1302–1307. https://doi.org/10.1902/jop.2003.74.9.1302 (2003).
Wang, C. T., Lin, Y. T., Chiang, B. L., Lee, S. S. & Hou, S. M. Over-expression of receptor activator of nuclear factor-kappa B ligand (RANKL), inflammatory cytokines, and chemokines in periprosthetic osteolysis of loosened whole hip arthroplasty. Biomaterials 31, 77–82. https://doi.org/10.1016/j.biomaterials.2009.09.017 (2010).
Salles, A. G., Antunes, L. A. A., Carvalho, P. A., Küchler, E. C. & Antunes, L. S. Affiliation between apical periodontitis and TNF-α -308 G>A gene polymorphism: A scientific overview and meta-analysis. Braz. Dent. J. 28, 535–542. https://doi.org/10.1590/0103-6440201701491 (2017).
